|Last Updated: February 16, 2020 @ 10:13 am|
|Stability:||Ambient: 2 Hour(s); Refrigerated: 7 Day(s); Frozen: 6 Month(s); Incubated: Unacceptable|
|Interpretive Data:||General Reference Range : 0-3.8 ng/ml|
Reference Range for Smokers is 0-5.5 ng/mL
The Roche e601 CEA electrochemiluminescent immunoassay is used. Results obtained with different assay methods or kits cannot be used interchangeably. Measurement of CEA has been shown to be clinically relevant in the management of patients with colorectal, breast, lung, prostatic, pancreatic, and ovarian carcinomas. The CEA assay value, regardless of level, should not be interpreted as evidence for the presence or absence of malignant disease and is not recommended for use as a screening procedure to detect the presence of cancer in the general population.
Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with this test and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.